HEMATOLOGICAL MALIGNANCIES
Clinical trials for HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stem cell transplant technique aims to reduce dangerous side effects in blood cancer patients
Disease control Not yet recruitingThis study tests a new way to do stem cell transplants for adults with high-risk blood cancers who don't have a fully matched donor. Doctors will use a special process to remove certain cells from the donated stem cells before transplant, hoping to lower the risk of severe graft-…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: NA • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
MRNA weapon takes aim at hard-to-treat blood cancers
Disease control Not yet recruitingThis early-phase study tests a new mRNA drug called WGb-0302 for people with blood cancers like multiple myeloma that have returned or stopped responding to standard treatments. The drug uses mRNA technology to help the body target a protein called BCMA found on cancer cells. Abo…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC